Drug Discovery 2022: driving the next life science revolution
Where: Innovation AveNEW 4 [Show on Floor Plan]
EXIT071 is a Leiden based startup developing cutting edge technology for novel biomarker discovery. We isolate and analyse exosomes - nanoparticles that come directly from cells and are filled with the same molecules as the parental cells. Exosomes are the snapshots of the health or disease state of cells and organs and have high potential in non-invasive diagnostics, novel therapeutics and biotechnology. Our proprietary technology platform will make the exosome based biomarker discovery a very fast, precise and automated high throughput process.
Tel: +31657052285
Address: Langegracht 70
Website: https://exit071.com/
Email: info@exit071.com

Find out more...

To view the virtial stand - please login first LinkedIn URL